Introduction ASCVD (Atherosclerotic cardiovascular disease) remains a leading cause of morbidity and mortality worldwide, driven by elevated levels of low-density lipoprotein cholesterol (LDL-C) (1). The standard of care includes statins, ezetimibe, and PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitors to achieve optimal LDL-C (Low d
50 Reached
Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes